file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
1601 | ERYTHRAEMIA | 1 | 0 | 53 |
1602 | INTERLEUKIN-6 | 2 | 8 | 53 |
1603 | ISOGRAFT | 1 | 13 | 53 |
1604 | ISOMERASE | 2 | 1 | 53 |
1605 | PEPTIC-ULCER | 2 | 5 | 53 |
1606 | REDUCED | 4 | 10 | 53 |
1607 | SEPTICEMIA | 1 | 2 | 53 |
1608 | SHEEP | 5 | 4 | 53 |
1609 | ARTERIOVENOUS | 2 | 0 | 52 |
1610 | CIMETIDINE | 2 | 0 | 52 |
1611 | CYTOMETRIC | 8 | 11 | 52 |
1612 | CYTOMETRY | 2 | 31 | 52 |
1613 | DRUG-FREE | 1 | 30 | 52 |
1614 | EFFECTIVENESS | 3 | 6 | 52 |
1615 | FREQUENT | 1 | 30 | 52 |
1616 | GENERATED | 4 | 11 | 52 |
1617 | HEART-LUNG | 2 | 20 | 52 |
1618 | HUMAN-LEUKEMIC | 1 | 1 | 52 |
1619 | INDEX | 2 | 8 | 52 |
1620 | MODULATION | 5 | 14 | 52 |
1621 | MONO-AND | 1 | 6 | 52 |
1622 | NATURE | 3 | 5 | 52 |
1623 | PIGS | 7 | 5 | 52 |
1624 | PLATELET | 4 | 1 | 52 |
1625 | PRELIMINARY-STUDY | 2 | 15 | 52 |
1626 | ULCERATION | 2 | 0 | 52 |
1627 | ADRENOCORTICAL | 1 | 32 | 51 |
1628 | ALLELES | 3 | 7 | 51 |
1629 | FUNCTIONALLY | 2 | 10 | 51 |
1630 | MALIGNANT | 3 | 0 | 51 |
# | Word | Recs | TLCS | TGCS |
1631 | POOL | 1 | 0 | 51 |
1632 | RELATIONSHIPS | 4 | 2 | 51 |
1633 | RENAL-ARTERIES | 3 | 0 | 51 |
1634 | REVERSING | 1 | 32 | 51 |
1635 | TC-99M-DTPA | 3 | 8 | 51 |
1636 | 10-YEAR | 3 | 5 | 50 |
1637 | 1990S | 1 | 7 | 50 |
1638 | ACCURACY | 1 | 3 | 50 |
1639 | BASIC | 5 | 3 | 50 |
1640 | BIOCHEMICAL | 4 | 4 | 50 |
1641 | DENERVATION | 2 | 2 | 50 |
1642 | ELEVATED | 2 | 10 | 50 |
1643 | ERYTHROID | 1 | 0 | 50 |
1644 | ETHICAL | 4 | 0 | 50 |
1645 | FOUR-YEAR | 1 | 3 | 50 |
1646 | GAMMA | 4 | 14 | 50 |
1647 | HYPOPLASIA | 1 | 0 | 50 |
1648 | LYMPHOBLASTIC | 2 | 6 | 50 |
1649 | MACROCYTOSIS | 1 | 0 | 50 |
1650 | MINOR | 6 | 26 | 50 |
1651 | PARENTAL | 3 | 12 | 50 |
1652 | PREVENT | 3 | 5 | 50 |
1653 | QUESTION | 1 | 21 | 50 |
1654 | SCHWANN | 2 | 2 | 50 |
1655 | STORAGE | 3 | 0 | 50 |
1656 | SURVEY | 3 | 12 | 50 |
1657 | TRIPLE | 3 | 6 | 50 |
1658 | VESSELS | 1 | 7 | 50 |
1659 | ANIMAL | 4 | 7 | 49 |
1660 | CHANGING | 6 | 4 | 49 |
# | Word | Recs | TLCS | TGCS |
1661 | DURATION | 1 | 7 | 49 |
1662 | FLT-3 | 3 | 19 | 49 |
1663 | INDUCING | 6 | 3 | 49 |
1664 | LETHAL | 5 | 8 | 49 |
1665 | ADENOVIRUS-MEDIATED | 2 | 2 | 48 |
1666 | ANTIMOUSE | 2 | 4 | 48 |
1667 | ATRESIA | 2 | 0 | 48 |
1668 | AVOID | 1 | 7 | 48 |
1669 | CONTINUING | 2 | 23 | 48 |
1670 | DETERMINE | 2 | 20 | 48 |
1671 | DOUBLE-BLIND-STUDY | 1 | 13 | 48 |
1672 | IMMUNOTOXIN | 2 | 3 | 48 |
1673 | LEGAL | 2 | 0 | 48 |
1674 | MICROBIAL | 2 | 0 | 48 |
1675 | NAIVE | 2 | 1 | 48 |
1676 | NEEDED | 2 | 24 | 48 |
1677 | NONINFECTIOUS | 1 | 2 | 48 |
1678 | PURIFIED | 3 | 7 | 48 |
1679 | SHORT | 4 | 4 | 48 |
1680 | STRUCTURE | 3 | 3 | 48 |
1681 | ANTI-CD40L | 1 | 16 | 47 |
1682 | AUSTRALIA | 2 | 4 | 47 |
1683 | FAILING | 2 | 7 | 47 |
1684 | FIVE | 2 | 3 | 47 |
1685 | FK778 | 2 | 2 | 47 |
1686 | FUSION | 1 | 0 | 47 |
1687 | HYPERTRICHOSIS | 1 | 2 | 47 |
1688 | IMMEDIATELY | 2 | 12 | 47 |
1689 | IMMUNOREACTIVE | 1 | 16 | 47 |
1690 | MATCHED-PAIR | 1 | 6 | 47 |
# | Word | Recs | TLCS | TGCS |
1691 | MEASURE | 2 | 6 | 47 |
1692 | MRNA | 2 | 4 | 47 |
1693 | NEURONAL | 3 | 1 | 47 |
1694 | NF-KAPPA | 2 | 2 | 47 |
1695 | OWN | 1 | 21 | 47 |
1696 | PERMITS | 2 | 8 | 47 |
1697 | PHENOTYPIC | 2 | 2 | 47 |
1698 | PRECONDITIONED | 1 | 16 | 47 |
1699 | SPLENIC | 3 | 5 | 47 |
1700 | STANDARD | 3 | 21 | 47 |
1701 | TOLERIZATION | 2 | 17 | 47 |
1702 | ANTI-REJECTION | 1 | 5 | 46 |
1703 | BIOCHEMICAL-CHARACTERIZATION | 1 | 0 | 46 |
1704 | CDNA | 1 | 0 | 46 |
1705 | COMPENSATORY | 2 | 0 | 46 |
1706 | CORTICOSTEROIDS | 7 | 4 | 46 |
1707 | COUPLETS | 1 | 0 | 46 |
1708 | CYCLOSPORINE-BINDING | 1 | 0 | 46 |
1709 | ENEMY | 1 | 9 | 46 |
1710 | EPIDERMAL-CELL | 1 | 1 | 46 |
1711 | IFN-GAMMA | 1 | 8 | 46 |
1712 | IMMUNOMODULATION | 5 | 19 | 46 |
1713 | PROCEDURES | 2 | 5 | 46 |
1714 | PUMP | 1 | 0 | 46 |
1715 | SEQUENCES | 1 | 0 | 46 |
1716 | TOXOPLASMA-GONDII | 1 | 0 | 46 |
1717 | TRIALOMANIA | 1 | 21 | 46 |
1718 | UROLOGIC | 1 | 2 | 46 |
1719 | WELL | 1 | 8 | 46 |
1720 | ALIMENTARY-TRACT | 1 | 1 | 45 |
# | Word | Recs | TLCS | TGCS |
1721 | AUTOIMMUNE-DISEASE | 2 | 9 | 45 |
1722 | CAUSED | 5 | 5 | 45 |
1723 | CD4 | 4 | 5 | 45 |
1724 | CYTOCHROME-P450 | 2 | 7 | 45 |
1725 | ENCEPHALOMYELITIS | 3 | 3 | 45 |
1726 | ENHANCE | 3 | 16 | 45 |
1727 | EXACERBATING | 1 | 3 | 45 |
1728 | PROSTAGLANDINS | 2 | 1 | 45 |
1729 | RECOGNITION | 1 | 1 | 45 |
1730 | REGIONAL | 2 | 3 | 45 |
1731 | REMOVAL | 2 | 8 | 45 |
1732 | SENSITIVITY | 2 | 4 | 45 |
1733 | T-REGULATORY | 1 | 7 | 45 |
1734 | ULTRASTRUCTURE | 2 | 5 | 45 |
1735 | VIRUS-INDUCED | 2 | 1 | 45 |
1736 | BABOONS | 4 | 6 | 44 |
1737 | CONSTITUENT | 1 | 2 | 44 |
1738 | CONTRIBUTING | 2 | 2 | 44 |
1739 | EPIGALLOCATECHIN-3-GALLATE | 1 | 2 | 44 |
1740 | EPISODIC | 1 | 0 | 44 |
1741 | EXAMINATION | 1 | 8 | 44 |
1742 | FEMORAL | 2 | 20 | 44 |
1743 | FETAL-MATERNAL | 3 | 6 | 44 |
1744 | INDIVIDUALITY | 2 | 2 | 44 |
1745 | KINASES | 1 | 2 | 44 |
1746 | LPS-INDUCED | 1 | 2 | 44 |
1747 | MARKEDLY | 2 | 7 | 44 |
1748 | MITOGEN-ACTIVATED | 1 | 2 | 44 |
1749 | MULTIPLE-ARTERY | 1 | 1 | 44 |
1750 | RATIONALE | 1 | 9 | 44 |
# | Word | Recs | TLCS | TGCS |
1751 | RELATIVE | 3 | 2 | 44 |
1752 | TEA | 1 | 2 | 44 |
1753 | UNIVERSITY-OF-PITTSBURGH | 1 | 9 | 44 |
1754 | BIOACTIVE | 1 | 0 | 43 |
1755 | CAMPATH-1M | 2 | 4 | 43 |
1756 | COLON | 1 | 0 | 43 |
1757 | DACLIZUMAB | 2 | 1 | 43 |
1758 | DEVELOPED | 3 | 4 | 43 |
1759 | FOCUS | 1 | 0 | 43 |
1760 | GUT | 2 | 0 | 43 |
1761 | GVHD | 3 | 11 | 43 |
1762 | HEMODYNAMICS | 4 | 2 | 43 |
1763 | IMMUNO | 2 | 1 | 43 |
1764 | IMPROVING | 1 | 3 | 43 |
1765 | LANDMARKS | 3 | 21 | 43 |
1766 | MEASURED | 1 | 2 | 43 |
1767 | MEDICAL | 2 | 0 | 43 |
1768 | MODALITIES | 1 | 0 | 43 |
1769 | PERFORATION | 1 | 0 | 43 |
1770 | PRODUCTS | 1 | 0 | 43 |
1771 | RENAL-DISEASE | 1 | 3 | 43 |
1772 | ABSENCE | 5 | 10 | 42 |
1773 | CLEARANCE | 4 | 3 | 42 |
1774 | DATABASE | 1 | 3 | 42 |
1775 | EXPANSION | 4 | 4 | 42 |
1776 | EXTRACTION | 2 | 0 | 42 |
1777 | HAIR-GROWTH | 1 | 5 | 42 |
1778 | PART | 4 | 9 | 42 |
1779 | PERIRENAL | 1 | 0 | 42 |
1780 | REAL-TIME | 3 | 8 | 42 |
# | Word | Recs | TLCS | TGCS |
1781 | SPLEEN | 15 | 12 | 42 |
1782 | SURVIVING | 5 | 17 | 42 |
1783 | SURVIVORS | 4 | 7 | 42 |
1784 | THEORETICAL | 2 | 0 | 42 |
1785 | UNOS | 2 | 3 | 42 |
1786 | WOMEN | 2 | 3 | 42 |
1787 | ADJUSTMENT | 1 | 2 | 41 |
1788 | ALLOREACTIVITY | 4 | 14 | 41 |
1789 | CIP1 | 1 | 2 | 41 |
1790 | CULTURES | 2 | 9 | 41 |
1791 | DAILY | 1 | 2 | 41 |
1792 | DENOMINATOR | 1 | 2 | 41 |
1793 | FIXED | 1 | 2 | 41 |
1794 | FOCAL | 3 | 0 | 41 |
1795 | IL-2 | 3 | 3 | 41 |
1796 | IMMUNOPATHOLOGY | 2 | 3 | 41 |
1797 | INTERLEUKIN-12 | 1 | 6 | 41 |
1798 | INTERLEUKIN-13 | 1 | 6 | 41 |
1799 | INTRAVENOUS-INFUSION | 1 | 11 | 41 |
1800 | JEJUNAL | 1 | 1 | 41 |